Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
06/2009
06/09/2009US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes
06/09/2009US7544667 Hypocholesterolemic compounds
06/04/2009WO2009069792A1 Amide compounds and plant disease controlling method using same
06/04/2009WO2009069736A1 Nitrogenated compound
06/04/2009WO2009068177A1 DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/04/2009US20090143590 Process for the Preparation of Montelukast and its Salts
06/04/2009US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
06/04/2009US20090143427 4-Oxoquinoline derivatives
06/04/2009US20090143425 Compounds affecting gap junction activity
06/04/2009US20090143389 Heterocyclic inhibitors of mek and methods of use thereof
06/04/2009US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
06/04/2009US20090143354 P2X7 Receptor Antagonists and Their Use
06/04/2009US20090142554 Yellow Azo Dyes for Ink Jet Printing
06/04/2009US20090142297 5-substituted isoindoline compounds
06/04/2009CA2706333A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor
06/03/2009EP2065372A1 Antitumor agent for undifferentiated gastric cancer
06/03/2009EP2064200A1 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization
06/03/2009EP2064185A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
06/03/2009EP1613319B1 Substituted phenyl acetamides and their use as protease inhibitors
06/03/2009CN101448790A Method of preparing 4-halogenated quinoline intermediates
06/03/2009CN100494177C Bi-amido heterocyclic derivative with antitumour activity and its preparation method and use
06/03/2009CN100494176C Method for extracting alkali metals or calcium salt of halogen or haloalkyl substituted 2-hydroxy pyridine, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
06/02/2009US7541467 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET)
06/02/2009US7541466 Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
06/02/2009US7541465 Substituted 2-aminoacetamides and the use thereof
06/02/2009US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases
06/02/2009CA2425395C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
05/2009
05/28/2009WO2009065503A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
05/28/2009WO2009030467A3 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
05/28/2009WO2009027482A3 Tsh receptor antagonizing tetrahydroquinoline compounds
05/28/2009US20090137585 N-acylsulfonamide apoptosis promoters
05/28/2009US20090137567 Methods for Treating Blood Disorders
05/28/2009US20090137564 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, A Process for Their Production and Their Use as Anti-inflammatory Agents
05/28/2009US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
05/28/2009US20090136561 Non-peptidyl agents with pHSP20-like activity, and uses thereof
05/28/2009CA2705410A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
05/27/2009EP2062959A2 Novel red electroluminescent compounds and organic electroluminescent device using the same
05/27/2009EP2062958A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/27/2009EP2062907A2 Metal coordination compound, luminescence device and display apparatus
05/27/2009EP2062901A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same
05/27/2009EP2062880A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
05/27/2009EP2061466A2 4-thio substituted quinoline and naphthyridine compounds
05/27/2009EP1487797B1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
05/27/2009CN101443314A Aminoquinolones as GSK-3 inhibitors
05/27/2009CN101443313A Quinoline derivatives and their use as pesticides
05/27/2009CN101443009A Antitumor agent for thyroid cancer
05/27/2009CN101443006A Novel benzylamine derivatives as CETP inhibitors
05/27/2009CN101440063A Preparation of piperaquini phosphatis
05/27/2009CN101440062A Synthesis of N-acyl-8-amino quinoline derivatives and use thereof as fluorescent molecular probe
05/27/2009CN100491354C Quinoline kind iriyellowsin electronic isostere and its preparation process and use
05/27/2009CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
05/26/2009US7538221 Polymorphs of racemic, dextrorotatory, and levorotatory enantioners of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesylate salts
05/26/2009US7538121 Vanilloid receptor modulators
05/26/2009CA2387201C Tetrahydroquinoline derivatives
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/22/2009WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
05/22/2009WO2009063070A2 Quinoline derivatives and their use as tyrosine kinase inhibitors
05/22/2009WO2009062289A1 Inhibitors of human immunodeficiency virus replication
05/22/2009WO2009062285A1 Inhibitors of human immunodeficiency virus replication
05/22/2009WO2009006861A3 A method for isolation and purification of montelukast
05/22/2009WO2008135671A3 Derivatives of the aminated hydroxyquinoline class for treating cancers
05/22/2009WO2007117778A9 Quinolones useful as inducible nitric oxide synthase inhibitors
05/22/2009CA2707418A1 Inhibitors of human immunodeficiency virus replication
05/22/2009CA2705820A1 Quinoline derivatives and their use as tyrosine kinase inhibitors
05/22/2009CA2705318A1 Inhibitors of human immunodeficiency virus replication
05/21/2009US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
05/21/2009US20090131456 Caspase inhibitors and uses thereof
05/21/2009US20090131435 Heterocyclic inhibitors of mek and methods of use
05/21/2009US20090131279 Nucleic acid fluorescent stains
05/21/2009US20090128009 Materials for organic electroluminescence devices
05/20/2009EP2059510A2 Sox-based kinase sensor
05/20/2009EP2059509A2 Process for the preparation of montelukast, and intermediates therefor
05/20/2009EP1270549B1 Polymer-immobilized alpha-iminoester
05/20/2009CN101437920A Electroluminescent material containing an organic luminescent substance
05/20/2009CN101437811A Quinoline derivatives
05/20/2009CN101437801A Process for production of 4-oxoquinoline compound
05/20/2009CN101437785A Method for producing 4-oxoquinoline compound
05/20/2009CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN100488950C Use of chemotherapeutic agents
05/19/2009US7534915 Non-symmetrical gelling agent
05/19/2009US7534891 Quinoline derivatives as H3R inverse agonists
05/19/2009US7534890 For example, 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-phenylmethoxy-(1H)-quinolin-2-one benzoate; beta-selective adrenoceptor agonists with potent bronchodilator activity
05/19/2009US7534889 5-HT4 receptor agonist compounds
05/19/2009US7534814 Mutilin derivatives and their use as antibacterials
05/19/2009US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
05/19/2009CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
05/19/2009CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
05/14/2009WO2009060945A1 Combination of anti-angiogenic substance and anti-tumor platinum complex
05/14/2009WO2009060835A1 Novel ubiquilin-binding small molecule
05/14/2009WO2009060209A1 6,6-fused bicyclic aromatic compounds and their therapeuti use
05/14/2009US20090124649 Aza spiro alkane derivatives as inhibitors of metalloproteases
05/14/2009US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors
05/14/2009US20090124617 Quinolone derivative or salt thereof
05/14/2009CA2704000A1 Combination of anti-angiogenic substance and anti-tumor platinum complex
05/13/2009EP2057122A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
05/13/2009EP2056823A2 8-hydroxyquinoline compounds and methods thereof
05/13/2009CN101432268A Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the ss2 adrenergic receptor
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 277